Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis

被引:34
作者
Reinwald, M. [1 ]
Uharek, L. [1 ]
Lampe, D. [2 ]
Grobosch, T. [2 ]
Thiel, E. [1 ]
Schwartz, S. [1 ]
机构
[1] Charite Campus Benjamin Franklin, Med Klin 3, Berlin, Germany
[2] Berliner Betrieb Zent Gesundheitliche Aufgaben, Inst Toxikol, Berlin, Germany
关键词
CENTRAL-NERVOUS-SYSTEM; BRAIN;
D O I
10.1038/bmt.2009.17
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
[No abstract available]
引用
收藏
页码:269 / 270
页数:2
相关论文
共 10 条
[1]   Drug targeting to the brain [J].
de Boer, A. G. ;
Gaillard, P. J. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 :323-355
[2]   Central nervous system aspergillosis in allogeneic stem cell transplant recipients [J].
Jantunen, E ;
Volin, L ;
Salonen, O ;
Piilonen, A ;
Parkkali, T ;
Anttila, VJ ;
Paetau, A ;
Ruutu, T .
BONE MARROW TRANSPLANTATION, 2003, 31 (03) :191-196
[3]   Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients [J].
Lutsar, I ;
Roffey, S ;
Troke, P .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :728-732
[4]   P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier [J].
Miyama, T ;
Takanaga, H ;
Matsuo, H ;
Yamano, K ;
Yamamoto, K ;
Iga, T ;
Naito, M ;
Tsuruo, T ;
Ishizuka, H ;
Kawahara, Y ;
Sawada, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1738-1744
[5]   In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans [J].
Perfect, JR ;
Cox, GM ;
Dodge, RK ;
Schell, WA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1910-1913
[6]   Posaconazole concentrations in the central nervous system [J].
Rueping, Maria J. G. T. ;
Albermann, Nadine ;
Ebinger, Friedrich ;
Burckhardt, Irene ;
Beisel, Claudia ;
Mueller, Carsten ;
Vehreschild, Joerg J. ;
Kochanek, Matthias ;
Faetkenheuer, Gerd ;
Bangard, Christopher ;
Ullmann, Andrew J. ;
Herr, Wolfgang ;
Kolbe, Karin ;
Hallek, Michael ;
Cornely, Oliver A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) :1468-1470
[7]   Improved outcome in central nervous system aspergillosis, using voriconazole treatment [J].
Schwartz, S ;
Ruhnke, M ;
Ribaud, P ;
Corey, L ;
Driscoll, T ;
Cornely, OA ;
Schuler, U ;
Lutsar, I ;
Troke, P ;
Thiel, E .
BLOOD, 2005, 106 (08) :2641-2645
[8]  
Schwartz S., 2004, Annals of Hematology, V83, pS42
[9]   Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease [J].
Ullmann, Andrew J. ;
Lipton, Jeffrey H. ;
Vesole, David H. ;
Chandrasekar, Pranatharthi ;
Langston, Amelia ;
Tarantolo, Stefano R. ;
Greinix, Hildegard ;
Morais de Azevedo, Wellington ;
Reddy, Vijay ;
Boparai, Navdeep ;
Pedicone, Lisa ;
Patino, Hernando ;
Durrant, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :335-347
[10]   Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases [J].
van Burik, JAH ;
Hare, RS ;
Solomon, HF ;
Corrado, ML ;
Kontoyiannis, DP .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :E61-E65